Novel Target Selection for Nuclear Medicine Studies
Sze Ting Lee1, I Burvenich2, A M Scott3
1Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.
Abstract:
Nuclear medicine techniques involving SPECT and PET are being increasingly used as a noninvasive tool for the detection, quantitation and therapy response monitoring of a myriad of disease processes through target visualization and kinetic modeling. The target selection requires a good understanding of the physiologic changes involved in the disease processes. The target selected can range from cellular proteins expressed in a particular organ, biochemical pathways in cells, or receptors on circulating blood cells. This can have a significant impact on therapeutic options for subsequent therapies, including radionuclide therapies in this evolving world of theranostic practices, which is outlined in this review.
Related Concept Videos
Nuclear Transmutation
10:03Isolation of CA1 Nuclear Enriched Fractions from Hippocampal Slices to Study Activity-dependent Nuclear Import of Synapto-nuclear Messenger Proteins
Nuclear Stability
To hold positively charged protons together...
Ethics in Target Audience Selection
Ethical targeting respects consumer privacy, avoids intrusive advertising, and ensures...
Nuclear Export of mRNA
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...


